Page last updated: 2024-11-05

zonisamide and Epilepsy Progressive Myoclonic 2

zonisamide has been researched along with Epilepsy Progressive Myoclonic 2 in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Seizures, especially myoclonus, are often refractary to antiepileptic drugs (AD)."2.82[Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy]. ( Álvarez-Pérez, P; Cores-Bartolomé, C; Lema-Facal, T; Rubio-Nazábal, E, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Rubio-Nazábal, E1
Álvarez-Pérez, P1
Cores-Bartolomé, C1
Lema-Facal, T1
Yoshimura, I1
Kaneko, S1
Yoshimura, N1
Murakami, T1

Reviews

1 review available for zonisamide and Epilepsy Progressive Myoclonic 2

ArticleYear
[Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
    Revista de neurologia, 2022, 09-16, Volume: 75, Issue:6

    Topics: Anticonvulsants; Humans; Lafora Disease; Myoclonic Epilepsies, Progressive; Myoclonus; Zonisamide

2022

Other Studies

1 other study available for zonisamide and Epilepsy Progressive Myoclonic 2

ArticleYear
Long-term observations of two siblings with Lafora disease treated with zonisamide.
    Epilepsy research, 2001, Volume: 46, Issue:3

    Topics: Adult; Anticonvulsants; Fatal Outcome; Female; Follow-Up Studies; Humans; Isoxazoles; Lafora Disease

2001